Trajectories of individual symptoms in remitters versus non-remitters with depression

H Sakurai, H Uchida, T Abe, S Nakajima… - Journal of affective …, 2013 - Elsevier
Background It remains unclear regarding the contribution of each individual symptom in
predicting the outcome in major depressive disorder (MDD). The objective of this analysis …

Predicting relapse with individual residual symptoms in major depressive disorder: a reanalysis of the STAR* D data

H Sakurai, T Suzuki, K Yoshimura, M Mimura… - …, 2017 - Springer
Background Residual symptoms are detrimental to prognosis in major depressive disorder
(MDD); however, little is known about the contribution of each residual symptom in …

Prognostic subgroups for citalopram response in the STAR* D trial

E Jakubovski, MH Bloch - The Journal of clinical psychiatry, 2014 - psychiatrist.com
Objective: Few data exist to help clinicians predict likelihood of treatment response in
individual patients with major depressive disorder (MDD). Our aim was to identify subgroups …

Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR* D report

AA Nierenberg, MM Husain, MH Trivedi… - Psychological …, 2010 - cambridge.org
BackgroundMany patients with major depressive disorder (MDD) who experience full
symptomatic remission after antidepressant treatment still have residual depressive …

Predictive socioeconomic and clinical profiles of antidepressant response and remission

FA Jain, AM Hunter, JO Brooks III… - Depression and …, 2013 - Wiley Online Library
Background There are many prognostic factors for treatment outcome in major depressive
disorder (MDD). The predictive power of any single factor, however, is limited. We aimed to …

Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD)

AG Wade, TE Schlaepfer, HF Andersen… - Journal of psychiatric …, 2009 - Elsevier
BACKGROUND: It is uncertain as to what short-term outcomes predict long-term treatment
compliance and outcomes in patients with MDD. AIMS: To determine what treatment …

Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication

SM McClintock, MM Husain… - Journal of clinical …, 2011 - journals.lww.com
Little is known about the quantity or quality of residual depressive symptoms in patients with
major depressive disorder (MDD) who have responded but not remitted with antidepressant …

Clinical and functional outcomes of patients who experience partial response to citalopram: secondary analysis of STAR* D

EB Dennehy, LB Marangell, J Martinez… - Journal of Psychiatric …, 2014 - journals.lww.com
Background. We analyzed the public STAR* D database to better characterize the baseline
clinical characteristics and functional outcomes of patients with major depressive disorder …

Predicting relapse from the time to remission during the acute treatment of depression: A re-analysis of the STAR* D data

K Kubo, H Sakurai, H Tani, K Watanabe… - Journal of Affective …, 2023 - Elsevier
Background Predicting relapse during maintenance treatment for depression is challenging.
The objective of this analysis was to investigate the association between the time taken to …

Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial

BW Dunlop, EB Binder, JF Cubells, MM Goodman… - Trials, 2012 - Springer
Background Limited controlled data exist to guide treatment choices for clinicians caring for
patients with major depressive disorder (MDD). Although many putative predictors of …